Literature DB >> 2823687

Supratentorial malignant gliomas in childhood: a review of fifty cases.

E J Dropcho1, J H Wisoff, R W Walker, J C Allen.   

Abstract

From 1977 to 1986, 50 children aged 15 months to 18 years were treated for supratentorial malignant gliomas at the Memorial Sloan-Kettering Cancer Center and the New York University Medical Center. Thirteen patients had glioblastoma multiforme, 29 had anaplastic astrocytomas, and 8 had malignant gliomas. In 10 patients the tumor evolved from a low-grade lesion. Seven patients, including 2 patients with neurofibromatosis, developed multiple primary malignant neoplasms. The median time to tumor progression after surgery was 31 weeks, with local recurrence representing the mode of treatment failure in nearly all patients. Notable clinical features included symptomatic leptomeningeal metastasis (13 patients) and intratumoral hemorrhage (9 patients). The estimated median survival time for all 50 patients was 98 weeks, with a 3-year survival rate of 32%. A trend toward longer survival was seen in patients 12 years of age or younger at diagnosis. There was no apparent correlation between survival and tumor histology or tumor location. Recommendations for management are presented.

Entities:  

Mesh:

Year:  1987        PMID: 2823687     DOI: 10.1002/ana.410220312

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Long-term survival in a patient with supratentorial glioblastoma: clinical considerations.

Authors:  L Cervoni; P Celli; M Salvati
Journal:  Ital J Neurol Sci       Date:  1998-08

2.  Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.

Authors:  Tae-Young Jung; Ji Yeoun Lee; Dong-Seok Kim; Hyeon Jin Park; Chae-Yong Kim; Young-Shin Ra; Mee-Jeong Lee; Seong-Ho Kim; Hee-Jo Baek; Il Han Kim; Kyung Duk Park; Seung-Ki Kim
Journal:  J Neurooncol       Date:  2014-11-04       Impact factor: 4.130

3.  Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma.

Authors:  A Broniscer; R G Tatevossian; N D Sabin; P Klimo; J Dalton; R Lee; A Gajjar; D W Ellison
Journal:  Neuropathol Appl Neurobiol       Date:  2014-04       Impact factor: 8.090

4.  Phase II trial of temozolomide in children with recurrent high-grade glioma.

Authors:  A Ruggiero; G Cefalo; M L Garré; M Massimino; C Colosimo; G Attinà; I Lazzareschi; P Maurizi; V Ridola; G Mazzarella; M Caldarelli; C Di Rocco; E Madon; M E Abate; A Clerico; A Sandri; R Riccardi
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

Review 5.  Treatments for astrocytic tumors in children: current and emerging strategies.

Authors:  Stanislaw R Burzynski
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

6.  Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).

Authors:  Martin Benesch; Sabine Wagner; Frank Berthold; Johannes E A Wolff
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

7.  Supratentorial glioblastoma in children: a series of 27 surgically treated cases.

Authors:  M Artico; L Cervoni; P Celli; M Salvati; L Palma
Journal:  Childs Nerv Syst       Date:  1993-02       Impact factor: 1.475

8.  Glioblastoma multiforme in children: experience at Hospital Infantil de Mexico Federico Gomez.

Authors:  Federico Sánchez-Herrera; Eduardo Castro-Sierra; Luis Felipe Gordillo-Domínguez; Miguel Angel Vaca-Ruiz; Blanca Santana-Montero; Mario Perezpeña-Diazconti; Vicente González-Carranza; Samuel Torres-García; Fernando Chico-Ponce de León
Journal:  Childs Nerv Syst       Date:  2009-01-16       Impact factor: 1.475

9.  Radical resection of focal brainstem gliomas: is it worth doing?

Authors:  Charles Teo; Timothy L Siu
Journal:  Childs Nerv Syst       Date:  2008-06-18       Impact factor: 1.475

10.  A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.

Authors:  Regina I Jakacki; Allan Yates; Susan M Blaney; Tianni Zhou; Robert Timmerman; Ashish M Ingle; Lynda Flom; Michael D Prados; Peter C Adamson; Ian F Pollack
Journal:  Neuro Oncol       Date:  2008-05-22       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.